INDOCO REMEDIES LIMITED

Location

Maharashtra

Founded

1947-08-23

Risk Signals

86 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about INDOCO REMEDIES LIMITED

Live alerts from global media, monitored by Business Radar

Indoco Remedies Q3 Results Review - Another Quarter Of Weak Margins: Prabhudas Lilladher

2024-01-24 (ndtvprofit.com)

Indoco Remedies Q3 Results Review - Another Quarter Of Weak Margins: Prabhudas Lilladher

Indoco Remedies Ltd.'s cut our FY25/FY26 earning per share by ~10%/4% to factor in low margins and lower sales across regulated markets. We downgrade stock from Buy to 'Accumulate' given weak earnings visibility, muted domestic formulation sales. Our numbers do factor in margin recovery with reduction in remediation cost from FY25. Indoco Remedies Q3 FY24 Ebitda was sharply below our estimates led by continued higher remediation cost and lower regulated market sales.

Read more

Never miss a headline about INDOCO REMEDIES LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages